{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:34:27Z","timestamp":1762868067607,"version":"3.44.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.antiviral.2020.104734","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T11:56:56Z","timestamp":1581335816000},"page":"104734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Long-chain fatty acyl-coenzyme A suppresses hepatitis C virus infection by targeting virion-bound lipoproteins"],"prefix":"10.1016","volume":"177","author":[{"given":"Xinlei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yetong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.antiviral.2020.104734_bib63","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","volume":"67","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"6173","key":"10.1016\/j.antiviral.2020.104734_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.1247749","article-title":"Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system","volume":"343","author":"Akey","year":"2014","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.antiviral.2020.104734_bib2","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","article-title":"Characterization of low- and very-low-density hepatitis C virus RNA-containing particles","volume":"76","author":"Andre","year":"2002","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2020.104734_bib3","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1462-5822.2007.00972.x","article-title":"Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection","volume":"9","author":"Andreo","year":"2007","journal-title":"Cell Microbiol."},{"issue":"10","key":"10.1016\/j.antiviral.2020.104734_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40265-017-0753-x","article-title":"Resistance mechanisms in hepatitis C virus: implications for direct-acting antiviral use","volume":"77","author":"Bagaglio","year":"2017","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104734_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jhep.2017.04.010","article-title":"Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity","volume":"67","author":"Bankwitz","year":"2017","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104734_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2010.04.015","article-title":"Hepatitis C virus replication cycle","volume":"53","author":"Bartenschlager","year":"2010","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104734_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tim.2010.11.005","article-title":"Assembly of infectious hepatitis C virus particles","volume":"19","author":"Bartenschlager","year":"2011","journal-title":"Trends Microbiol."},{"issue":"18","key":"10.1016\/j.antiviral.2020.104734_bib8","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1073\/pnas.0902693106","article-title":"Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication","volume":"106","author":"Berger","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.antiviral.2020.104734_bib9","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourliere","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"10.1016\/j.antiviral.2020.104734_bib10","doi-asserted-by":"crossref","first-page":"18904","DOI":"10.1074\/jbc.M113.538256","article-title":"The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles","volume":"289","author":"Boyer","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104734_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3350\/cmh.2016.0107","article-title":"Management of direct antiviral agent failures","volume":"22","author":"Buti","year":"2016","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104734_bib12","doi-asserted-by":"crossref","first-page":"27778","DOI":"10.1038\/srep27778","article-title":"Cell-death-inducing DFFA-like effector B contributes to the assembly of hepatitis C virus (HCV) particles and interacts with HCV NS5A","volume":"6","author":"Cai","year":"2016","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.antiviral.2020.104734_bib13","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1073\/pnas.1307527110","article-title":"Ultrastructural analysis of hepatitis C virus particles","volume":"110","author":"Catanese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"24","key":"10.1016\/j.antiviral.2020.104734_bib14","doi-asserted-by":"crossref","first-page":"13783","DOI":"10.1128\/JVI.01091-07","article-title":"Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture","volume":"81","author":"Chang","year":"2007","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.antiviral.2020.104734_bib15","doi-asserted-by":"crossref","first-page":"11532","DOI":"10.1128\/JVI.01021-10","article-title":"The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus","volume":"84","author":"Cun","year":"2010","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104734_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jhep.2018.11.033","article-title":"A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu","volume":"70","author":"Denolly","year":"2019","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104734_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1473-3099(16)30408-X","article-title":"Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study","volume":"17","author":"Deterding","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104734_bib18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2017.11.007","article-title":"Patterns of resistance-associated substitutions in patients with chronic HCV infection following treatment with direct-acting antivirals","volume":"154","author":"Dietz","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104734_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.12688\/f1000research.7354.1","article-title":"Recent advances in understanding hepatitis C","volume":"5","author":"Douam","year":"2016","journal-title":"F1000Res"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2020.104734_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2893.2007.00919.x","article-title":"The scavenger receptor BI and its ligand, HDL: partners in crime against HCV neutralizing antibodies","volume":"14","author":"Dreux","year":"2007","journal-title":"J. Viral Hepat."},{"issue":"11","key":"10.1016\/j.antiviral.2020.104734_bib21","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.1322036111","article-title":"Structural basis of Flavivirus NS1 assembly and antibody recognition","volume":"111","author":"Edeling","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104734_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nano.2013.06.004","article-title":"Dengue virus capsid protein interacts specifically with very low-density lipoproteins","volume":"10","author":"Faustino","year":"2014","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104734_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.gastro.2015.09.014","article-title":"Apolipoprotein E mediates evasion from hepatitis C virus neutralizing antibodies","volume":"150","author":"Fauvelle","year":"2016","journal-title":"Gastroenterology"},{"issue":"27","key":"10.1016\/j.antiviral.2020.104734_bib24","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"10.1016\/j.antiviral.2020.104734_bib25","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection","volume":"373","author":"Foster","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104734_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep.30225","article-title":"Frequent antiviral treatment failures in patients infected with hepatitis C virus genotype 4, subtype 4r","volume":"69","author":"Fourati","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.antiviral.2020.104734_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006475","article-title":"Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae","volume":"13","author":"Fukuhara","year":"2017","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.antiviral.2020.104734_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004534","article-title":"Amphipathic alpha-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles","volume":"10","author":"Fukuhara","year":"2014","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104734_bib29","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/JVI.02053-07","article-title":"Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion","volume":"82","author":"Gastaminza","year":"2008","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104734_bib30","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.antiviral.2020.104734_bib31","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1128\/JVI.00577-15","article-title":"Apolipoprotein E, but not apolipoprotein B, is essential for efficient cell-to-cell transmission of hepatitis C virus","volume":"89","author":"Gondar","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104734_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.coviro.2014.07.010","article-title":"Resistance to nucleotide analogue inhibitors of hepatitis C virus NS5B: mechanisms and clinical relevance","volume":"8","author":"Gotte","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2020.104734_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-nutr-071813-105541","article-title":"Acyl-CoA metabolism and partitioning","volume":"34","author":"Grevengoed","year":"2014","journal-title":"Annu. Rev. Nutr."},{"issue":"19","key":"10.1016\/j.antiviral.2020.104734_bib34","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1073\/pnas.1017338108","article-title":"Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein","volume":"108","author":"Gutsche","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.antiviral.2020.104734_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbalip.2011.05.010","article-title":"Analysis of mammalian fatty acyl-coenzyme A species by mass spectrometry and tandem mass spectrometry","volume":"1811","author":"Haynes","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.antiviral.2020.104734_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri3463","article-title":"25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end","volume":"13","author":"Heim","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"6675","key":"10.1016\/j.antiviral.2020.104734_bib37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/33185","article-title":"Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha","volume":"392","author":"Hertz","year":"1998","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.antiviral.2020.104734_bib38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0006-2952(01)00578-0","article-title":"Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators","volume":"61","author":"Hertz","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104734_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002860","article-title":"Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis","volume":"8","author":"Hirata","year":"2012","journal-title":"PLoS Pathog."},{"issue":"22","key":"10.1016\/j.antiviral.2020.104734_bib40","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1128\/JVI.01063-10","article-title":"Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms","volume":"84","author":"Hishiki","year":"2010","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.antiviral.2020.104734_bib41","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.3390\/v6114227","article-title":"Resistance patterns associated with HCV NS5A inhibitors provide limited insight into drug binding","volume":"6","author":"Issur","year":"2014","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104734_bib42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12072-018-9878-6","article-title":"Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals","volume":"12","author":"Izumi","year":"2018","journal-title":"Hepatol. Int."},{"issue":"13","key":"10.1016\/j.antiviral.2020.104734_bib43","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1128\/JVI.07222-11","article-title":"Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate","volume":"86","author":"Jiang","year":"2012","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.antiviral.2020.104734_bib44","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1128\/JVI.01476-09","article-title":"Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles","volume":"83","author":"Jiang","year":"2009","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2020.104734_bib45","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1073\/pnas.0409834102","article-title":"Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids","volume":"102","author":"Kapadia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.antiviral.2020.104734_bib46","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1128\/JVI.02460-05","article-title":"Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses","volume":"80","author":"Koutsoudakis","year":"2006","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.antiviral.2020.104734_bib47","doi-asserted-by":"crossref","first-page":"12422","DOI":"10.1128\/JVI.01660-14","article-title":"Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins","volume":"88","author":"Lee","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104734_bib48","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/JVI.02068-13","article-title":"Hepatocyte nuclear factor 4alpha and downstream secreted phospholipase A2 GXIIB regulate production of infectious hepatitis C virus","volume":"88","author":"Li","year":"2014","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2020.104734_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070390","article-title":"Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"issue":"18","key":"10.1016\/j.antiviral.2020.104734_bib50","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1073\/pnas.1203829109","article-title":"Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104734_bib51","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2013.11.009","article-title":"Differential sensitivity of 5\u2019UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"issue":"48","key":"10.1016\/j.antiviral.2020.104734_bib52","doi-asserted-by":"crossref","first-page":"19757","DOI":"10.1073\/pnas.1218260109","article-title":"Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104734_bib53","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1053\/j.gastro.2011.06.010","article-title":"Mouse hepatic cells support assembly of infectious hepatitis C virus particles","volume":"141","author":"Long","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104734_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2012.02.008","article-title":"Cholesterol uptake and hepatitis C virus entry","volume":"57","author":"Lupberger","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104734_bib55","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1038\/srep04549","article-title":"Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes","volume":"4","author":"Lyn","year":"2014","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.antiviral.2020.104734_bib56","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0022-2275(20)32001-0","article-title":"Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice","volume":"41","author":"Maugeais","year":"2000","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104734_bib57","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.24523","article-title":"Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes","volume":"54","author":"Mazumdar","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104734_bib58","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1074\/jbc.M110.175018","article-title":"Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome","volume":"286","author":"Merz","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104734_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.antiviral.2020.104734_bib60","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1473-3099(15)70099-X","article-title":"Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial","volume":"15","author":"Mizokami","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"21","key":"10.1016\/j.antiviral.2020.104734_bib61","doi-asserted-by":"crossref","first-page":"12311","DOI":"10.1128\/JVI.01678-14","article-title":"Stearoyl coenzyme A desaturase 1 is associated with hepatitis C virus replication complex and regulates viral replication","volume":"88","author":"Nguyen","year":"2014","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104734_bib62","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/JVI.80.5.2418-2428.2006","article-title":"Association between hepatitis C virus and very-low-density lipoprotein (VLDL)\/LDL analyzed in iodixanol density gradients","volume":"80","author":"Nielsen","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104734_bib64","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1152\/ajpendo.90897.2008","article-title":"Biochemical and physiological function of stearoyl-CoA desaturase","volume":"297","author":"Paton","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104734_bib65","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1572-0241.2003.07402.x","article-title":"Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis","volume":"98","author":"Petit","year":"2003","journal-title":"Am. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104734_bib67","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/gutjnl-2016-311726","article-title":"Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture","volume":"66","author":"Piver","year":"2017","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.antiviral.2020.104734_bib68","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/JVI.01760-10","article-title":"Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics","volume":"85","author":"Pokrovskii","year":"2011","journal-title":"J. Virol."},{"issue":"18","key":"10.1016\/j.antiviral.2020.104734_bib69","doi-asserted-by":"crossref","first-page":"15736","DOI":"10.1074\/jbc.M200971200","article-title":"Polyunsaturated fatty acyl coenzyme A suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha","volume":"277","author":"Rajas","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104734_bib70","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.26660","article-title":"Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors","volume":"59","author":"Ramirez","year":"2014","journal-title":"Hepatology"},{"issue":"7503","key":"10.1016\/j.antiviral.2020.104734_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/510043a","article-title":"Hepatitis C: treatment triumphs","volume":"510","author":"Rice","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.antiviral.2020.104734_bib72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104734_bib73","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.gastro.2016.06.002","article-title":"Prevalence of resistance-associated substitutions in HCV NS5A, NS5B, or NS3 and outcomes of treatment with ledipasvir and sofosbuvir","volume":"151","author":"Sarrazin","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.antiviral.2020.104734_bib74","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1053\/j.gastro.2007.02.037","article-title":"Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir","volume":"132","author":"Sarrazin","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104734_bib75","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cld.2017.03.004","article-title":"Metabolic manifestations of hepatitis C virus: diabetes mellitus, dyslipidemia","volume":"21","author":"Serfaty","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104734_bib76","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0168-8278(00)00036-2","article-title":"Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C","volume":"34","author":"Serfaty","year":"2001","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104734_bib77","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/hep.26566","article-title":"Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers","volume":"58","author":"Steenbergen","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104734_bib78","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2009.09.006","article-title":"A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles","volume":"395","author":"Tao","year":"2009","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.antiviral.2020.104734_bib79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0022-2275(20)32059-9","article-title":"Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice","volume":"41","author":"Tsukamoto","year":"2000","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.antiviral.2020.104734_bib80","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"issue":"21","key":"10.1016\/j.antiviral.2020.104734_bib81","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1128\/JVI.01353-16","article-title":"Neglected but important role of apolipoprotein E exchange in hepatitis C virus infection","volume":"90","author":"Yang","year":"2016","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104734_bib82","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1074\/jbc.M706160200","article-title":"Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells","volume":"283","author":"Yao","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104734_bib83","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1371\/journal.ppat.0030108","article-title":"Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus","volume":"3","author":"Ye","year":"2007","journal-title":"PLoS Pathog."},{"issue":"26","key":"10.1016\/j.antiviral.2020.104734_bib84","doi-asserted-by":"crossref","first-page":"15865","DOI":"10.1073\/pnas.2237238100","article-title":"Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation","volume":"100","author":"Ye","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104734_bib85","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jhep.2017.01.007","article-title":"NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome","volume":"66","author":"Zeuzem","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104734_bib86","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2016.09.033","article-title":"Infection of hepatocytes with HCV increases cell surface levels of heparan sulfate proteoglycans, uptake of cholesterol and lipoprotein, and virus entry by up-regulating SMAD6 and SMAD7","volume":"152","author":"Zhang","year":"2017","journal-title":"Gastroenterology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:30:54Z","timestamp":1759062654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219304851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":85,"alternative-id":["S0166354219304851"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104734","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-chain fatty acyl-coenzyme A suppresses hepatitis C virus infection by targeting virion-bound lipoproteins","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104734"}}